Göran Ahlgren (Former)
1 – 35 of 35
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14)
(
- Contribution to journal › Article
- 2022
-
Mark
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy - The PROPER 1 trial
(
- Contribution to journal › Article
- 2021
-
Mark
Association of surgeon and hospital volume with short-term outcomes after robotassisted radical prostatectomy : Nationwide, population-based study
(
- Contribution to journal › Article
-
Mark
Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
(
- Contribution to journal › Article
- 2020
-
Mark
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study
(
- Contribution to journal › Article
- 2019
-
Mark
Population-based, nationwide registration of prostatectomies in Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer : Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial
(
- Contribution to journal › Article
- 2017
-
Mark
Prostatacancercentrum - navet i framtidens prostatacancersjukvård
(
- Contribution to journal › Article
-
Mark
Long-term functional outcomes after radical cystectomy with ileal bladder substitute : does the definition of continence matter?
(
- Contribution to journal › Article
-
Mark
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301) : An open-label, phase 3, randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Podocalyxin-like and rna-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer : A validatory study
(
- Contribution to journal › Article
-
Mark
Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease : Semi-ecologic, Nationwide, Population-based Study
(
- Contribution to journal › Article
-
Mark
Prostatacancercentrum – navet i framtidens prostatacancersjukvård - En vision som är i linje med det nationella vårdprogrammets riktlinjer : En vision som är i linje med det nationella vårdprogrammets riktlinjer
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Reduction of quality of life in prostate cancer patients : experience among 6200 men in the Nordic countries
(
- Contribution to journal › Article
-
Mark
Value of treatment in clinical trials versus the real world : the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer patients in Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
Salvage cryotherapy for local recurrence after radiotherapy for prostate cancer
(
- Contribution to journal › Article
-
Mark
Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.
(
- Contribution to journal › Scientific review
-
Mark
Development of a standardised training curriculum for robotic surgery: a consensus statement from an international multidisciplinary group of experts
(
- Contribution to journal › Article
-
Mark
(18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy.
(
- Contribution to journal › Article
- 2014
-
Mark
(18)F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
(
- Contribution to journal › Article
-
Mark
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
(
- Contribution to journal › Article
-
Mark
Dietary intakes of carbohydrates in relation to prostate cancer risk: a prospective study in the Malmo Diet and Cancer cohort.
(
- Contribution to journal › Article
-
Mark
A Plea for Surgical Lymph Node Staging in Advanced Prostate Cancer.
2012) In European Urology(
- Contribution to journal › Letter
- 2011
-
Mark
NATION-WIDE POPULATION-BASED STUDY ON 15-YEAR MORTALITY IN PROSTATE CANCER ACCORDING TO RISK CATEGORIES IN THE NATIONAL PROSTATE CANCER REGISTER (NPCR) OF SWEDEN
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.324-325(
- Contribution to journal › Published meeting abstract
-
Mark
Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial
(
- Contribution to journal › Article
- 2010
-
Mark
System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer.
(
- Contribution to journal › Article
- 2009
-
Mark
Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer.
(
- Contribution to journal › Article
- 2008
-
Mark
Nerve-sparing radical prostatectomy results in more patients with preserved sexual function but does not correlate to less bother on sexual function 2 years after surgery
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.241-241(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 - Data from the national prostate cancer register in Sweden
(
- Contribution to journal › Article
- 2005
-
Mark
The 5alpha-Reductase Type II A49T and V89L High-Activity Allelic Variants are More Common in Men with Prostate Cancer Compared with the General Population.
(
- Contribution to journal › Article
- 2002
-
Mark
Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial
(
- Contribution to journal › Article
- 1999
-
Mark
Prognostic factors in prostate cancer with special reference to the effect of hormonal therapy
1999)(
- Thesis › Doctoral thesis (compilation)
- 1995
-
Mark
Impaired Secretory Function of the Prostate in Men With Oligo‐Asthenozoospermia
(
- Contribution to journal › Article